Recurrent activating MAPK pathway gene mutations in Langerhans cell histiocytosis

被引:0
|
作者
Chakraborty, R. [1 ]
Hampton, O. A. [2 ,3 ]
Shen, Xiaoyun [1 ]
Simko, S. J. [1 ,4 ]
Shih, A. [1 ]
Abhyankar, H. [1 ]
Lim, K. P. H. [1 ,5 ]
Covington, K. R. [2 ,3 ]
Trevino, L. [2 ,3 ]
Dewal, N. [2 ,3 ]
Muzny, D. M. [3 ]
Doddapaneni, H. [3 ]
Hu, J. [3 ]
Wang, L. [2 ,3 ]
Lupo, P. J. [1 ,4 ]
Hicks, M. J. [1 ,4 ,6 ,8 ]
Bonilla, D. L. [7 ,8 ]
Dwyer, K. C. [2 ,7 ,8 ]
Berres, M. L. [9 ,10 ]
Poulikakos, P. I. [9 ,11 ]
Merad, M. [9 ,10 ]
McClain, K. L. [1 ,4 ]
Wheeler, D. A. [2 ,3 ]
Parsons, D. W. [1 ,2 ,3 ,4 ,5 ]
Allen, C. E. [1 ,4 ,5 ]
机构
[1] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[3] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA
[4] Baylor Coll Med, Div Pediat Hematol Oncol, Dept Pediat, Houston, TX 77030 USA
[5] Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA
[6] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA
[7] Univ Texas MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[8] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA
[9] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[10] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA
[11] Icahn Sch Med, Dept Dermatol, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
30
引用
收藏
页码:18 / 18
页数:1
相关论文
共 50 条
  • [21] Cholesteatoma Masquerading as Recurrent Langerhans Cell Histiocytosis
    Gendre, Adrien
    Dreno, Marine
    Boyer, Julie
    Thomas, Caroline
    Michel, Guillaume
    JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY, 2023, 19 (01): : 70 - 73
  • [22] Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis
    Kemps, Paul G.
    Woei-A-Jin, F. J. Sherida H.
    Quint, Koen D.
    van den Bos, Cor
    Naeije, Leonie
    van Laar, Jan A. M.
    Bempt, Isabelle Vanden
    Koudijs, Marco J.
    Vorderman, Ruben H. P.
    Stelloo, Ellen
    Swennenhuis, Joost F.
    Bruggink, Annette H.
    Hebeda, Konnie M.
    Scheijde-Vermeulen, Marijn A.
    Diercks, Gilles F. H.
    Verdijk, Robert M.
    Jansen, Patty M.
    Hauben, Esther
    Tousseyn, Thomas
    Cleven, Arjen H. G.
    van Wezel, Tom
    Halteren, Astrid G. S. van
    Hogendoorn, Pancras C. W.
    BLOOD ADVANCES, 2025, 9 (03) : 439 - 444
  • [23] Gene expression in Langerhans Cell histiocytosis
    McClain, KL
    Cai, YH
    Hicks, J
    Peterson, LE
    Ginsberg, SD
    PEDIATRIC RESEARCH, 2003, 53 (04) : 288A - 289A
  • [24] Clinical Outcomes and Molecular Responses in Children with Langerhans Cell Histiocytosis Treated with MAPK Pathway Inhibitors
    Eckstein, Olive S.
    Zinn, Daniel
    Levy, Carolyn Fein
    Henry, Michael M.
    Campbell, Patrick
    Jordan, Michael B.
    Kumar, Ashish R.
    Rodriguez-Galindo, Carlos
    Hijiya, Nobuko
    Abla, Oussama
    McClain, Kenneth L.
    Allen, Carl E.
    BLOOD, 2018, 132
  • [25] Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutations
    Tran, Gary
    Huynh, Thy N.
    Paller, Amy S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03) : 579 - +
  • [26] CLINICAL OUTCOMES WITH MAPK INHIBITION IN PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS
    Eckstein, Olive
    Zinn, Daniel
    Visser, Johannes
    Levy, Carolyn Fein
    Karras, Nicole
    Henry, Michael
    Campbell, Patrick
    Jordan, Michael
    Kumar, Ashish
    Rodriguez-Galindo, Carlos
    McClain, Kenneth
    Allen, Carl
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [27] CLINICAL OUTCOMES WITH MAPK INHIBITION FOR PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS
    Eckstein, Olive S.
    Zinn, Daniel J.
    Peckham-Gregory, Erin
    Abhyankar, Harshal
    Visser, Johannes
    Levy, Carolyn Fein
    Henry, Michael
    Campbell, Patrick
    Jordan, Michael
    Kumar, Ashish
    Chu, Roland
    Hijiya, Nobuko
    Young, Sun
    Karras, Nicole
    Abla, Oussama
    Rodriguez-Galindo, Carlos
    McClain, Kenneth L.
    Allen, Carl E.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S10 - S11
  • [28] Treatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibition
    Abla, Oussama
    Weitzman, Sheila
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 565 - 570
  • [29] RECURRENT PNEUMOTHORAX SECONDARY TO PULMONARY LANGERHANS CELL HISTIOCYTOSIS
    Prince, Jacob
    Tsai, Kathryn
    Khalid, Yousra
    Nguyen-Truong, Michael
    Tran, Peter
    Tang, Ashley
    Haider, Mobeen
    Gao, Lianghe
    CHEST, 2024, 166 (04) : 3527A - 3528A
  • [30] Adult Langerhans cell histiocytosis with recurrent vulvar ulcers
    Emiroglu, Nazan
    Dizman, Didem
    Cengiz, Fatma Pelin
    Gecer, Melin Ozgun
    Onsun, Nahide
    DERMATOLOGIC THERAPY, 2020, 33 (03)